Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Madrigal Pharmaceuticals Inc (MDGL)  
$229.58 5.27 (2.24%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 19,740,000
Market Cap: 4.53(B)
Last Volume: 9,322,967 Avg Vol: 9,297,425
52 Week Range: $120.4 - $284.88
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 21.9
Insider 3/6 Months : 22.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Co.'s primary product candidate, resmetirom, is being developed as a once-daily oral pill to treat several disease states, including non-alcoholic steatohepatitis, or NASH. Co. has initiated MAESTRO-NASH, a Phase 3 trial in NASH with its once daily, oral thyroid hormone receptor beta selective agonist, resmetirom. Co. has opened for enrollment MAESTRO-NAFLD-1, a Phase 3 clinical study of patients with biopsy-confirmed or presumed NASH recruited from sites in the U.S.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 136,370 424,685 424,685
Total Buy Value $0 $30,065,193 $77,751,391 $77,751,391
Total People Bought 0 1 1 1
Total Buy Transactions 0 3 10 10
Total Shares Sold 276,067 293,667 293,667 363,156
Total Sell Value $67,426,178 $71,246,652 $71,246,652 $90,715,080
Total People Sold 7 8 8 9
Total Sell Transactions 15 23 23 28
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 416
  Page 7 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Kovner Bruce Director   –       •       •   2015-12-02 4 S $0.43 $293,744 I/I (687,603) 987,690     -
   Kovner Bruce Director   –       •       •   2015-12-01 4 S $0.43 $206,804 I/I (480,716) 1,236,705     -
   Kovner Bruce Director   –       •       •   2015-11-30 4 S $0.43 $277,659 I/I (640,505) 1,410,796     -
   Kovner Bruce Director   –       •       •   2015-11-27 4 S $0.50 $462,625 I/I (934,595) 1,642,755     -
   Kovner Bruce Director   –       •       •   2015-11-25 4 S $0.49 $733,966 I/I (1,503,720) 1,981,218     -
   Kovner Bruce Director   –       •       •   2015-11-24 4 S $0.44 $237,476 I/I (538,129) 2,525,789     -
   Kovner Bruce Director   –       •       •   2015-11-23 4 S $0.44 $277,629 I/I (635,453) 2,720,672     -
   Kovner Bruce Director   –       •       •   2015-11-20 4 S $0.44 $102,038 I/I (230,283) 2,950,801     -
   Kovner Bruce Director   –       •       •   2015-11-19 4 S $0.46 $585,331 I/I (1,174,651) 3,034,198     -
   Kovner Bruce Director   –       •       •   2015-11-18 4 S $0.43 $46,820 I/I (108,154) 992,953     -
   Gollust Keith R Director   –       •      –    2015-11-17 4 S $0.41 $41,400 I/I (100,000) 2,885,061     -
   Kovner Bruce Director   –       •       •   2015-11-17 4 S $0.42 $295,661 I/I (700,618) 1,101,107     -
   Kovner Bruce Director   –       •       •   2015-11-16 4 S $0.44 $6,759 I/I (15,530) 1,801,725     -
   Kovner Bruce Director   –       •       •   2015-11-13 4 S $0.43 $219,568 I/I (507,788) 1,817,255     -
   Kovner Bruce Director   –       •       •   2015-11-12 4 S $0.47 $347,783 I/I (733,564) 2,325,043     -
   Kovner Bruce Director   –       •       •   2015-11-11 4 S $0.50 $538,201 I/I (1,080,941) 3,058,607     -
   Gollust Keith R Director   –       •      –    2015-11-10 4 S $0.55 $103,050 I/I (188,322) 2,985,061     -
   Kovner Bruce Director   –       •       •   2015-11-10 4 S $0.55 $769,111 I/I (1,397,114) 4,139,548     -
   Kovner Bruce Director   –       •       •   2015-11-09 4 S $0.61 $1,354,168 I/I (2,225,054) 5,536,662     -
   Kovner Bruce Director   –       •       •   2015-09-30 4 D $0.00 $0 I/I (4,120,854) 11,399,464     -
   Kovner Bruce Director   –       •       •   2015-09-30 4 A $0.00 $0 I/I 4,120,854 4,000,000     -
   Reardon William S Director   –       •      –    2015-07-01 4 A $0.00 $0 D/D 7,953 49,392     -
   Gollust Keith R Director   –       •      –    2015-07-01 4 A $0.00 $0 D/D 49,998 401,764     -
   Friedman Paul A Director   –       •      –    2015-07-01 4 A $0.00 $0 D/D 6,817 6,817     -
   Wilson Robert N Director   –       •      –    2015-07-01 4 A $0.00 $0 D/D 6,818 760,936     -

  416 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed